(Click to play video.)
Imagin Medical Inc. (CSE: IME) is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive procedures. The Company believes its first product, the i/Blue™ Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting cancer for removal, helping to reduce recurrence rates. The Company’s initial focus is bladder cancer, the sixth most prevalent cancer in North America and the third most prevalent cancer among men, with a recurrence rate of more than 50%.
Keynote speaker
Jim Hutchens, President and CEO of Imagin Medical
Participants
Ashish M. Kamat, MD - M.D. Anderson Cancer Center, Houston
Alexandre Zlotta, MD - Director of Uro-Oncology, Mt Sinai Hospital, Toronto
Mehrdad Alemozaffar, MD - Kaiser Permanente, Los Angeles
Ron Insana - Senior Analyst, CNBC and Financial Industry Expert
Learn more at
www.imaginmedical.com
FULL DISCLOSURE: Imagin Medical Inc. is a client of Stockhouse Publishing.